Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx Industry Should Support Imports To Block Other Price Controls – Attorney

Executive Summary

Drug manufacturers should support a legalized drug importation system because it is the most benign form of cost containment facing the industry, Mayer, Brown, Rowe & Maw Partner Alvin Lorman said

You may also be interested in...



Reimportation Advocates Have Support Of “Rogue” Pfizer Exec

The pharmaceutical industry's experience with parallel trade in Europe demonstrates that safety concerns should not prevent Rx importation in the U.S., according to a Pfizer exec

Senate Drug Import Bill Would Require Notice Of Manufacturing Changes

Drug manufacturers would be required to notify FDA of any manufacturing changes that might serve to circumvent reimportation under bipartisan legislation introduced by Sens. Byron Dorgan (D-N.D.) and Edward Kennedy (D-Mass.) April 21

Genentech Rx For Global Pricing: Refuse To Sell Unless Price Is “Reasonable”

Pharmaceutical companies should not market products in countries that do not allow "reasonable" prices for drugs, Genentech CEO Arthur Levinson declared during a March 12 investor conference

Topics

UsernamePublicRestriction

Register

OM008605

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel